Theriva Biologics, Inc.
TOVX
$0.4996
-$0.0304-5.74%
AMEX
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -4.32M | -4.45M | -7.73M | -8.32M | -5.17M |
| Total Depreciation and Amortization | 26.00K | 27.00K | 33.00K | 38.00K | 39.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -168.00K | 245.00K | 3.53M | 3.84M | 247.00K |
| Change in Net Operating Assets | -290.00K | -516.00K | 253.00K | 991.00K | -2.00K |
| Cash from Operations | -4.76M | -4.69M | -3.91M | -3.45M | -4.88M |
| Capital Expenditure | -- | 0.00 | 0.00 | -1.00K | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | 0.00 | 0.00 | -1.00K | -- |
| Total Debt Issued | 1.40M | -- | -- | -- | -- |
| Total Debt Repaid | -56.00K | 0.00 | 0.00 | -67.00K | -- |
| Issuance of Common Stock | -- | 7.00K | 3.72M | 1.84M | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 1.73M | -- | -- | -- | -- |
| Cash from Financing | 3.07M | 7.00K | 3.72M | 1.77M | -- |
| Foreign Exchange rate Adjustments | 93.00K | -123.00K | 17.00K | 12.00K | -38.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -1.59M | -4.81M | -180.00K | -1.67M | -4.92M |